Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

Abstract

Hyperphosphatemia was independently and consistently associated with an increased bone fracture risk, suggesting serum phosphate could be a novel risk factor for bone fractures in haemodialysis patients.